An der Goldgrube 12
Mainz 55131
Germany
49 6131 9084 0
https://www.biontech.de
Setor(es): Healthcare
Indústria: Biotechnology
Funcionários Integrais: 6.133
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Dr. Ugur Sahin M.D. | Co-Founder, CEO & Chair of the Management Board | 6,23M | N/A | 1965 |
Dr. Ozlem Tureci M.D. | Co-Founder, Chief Medical Officer & Member of Management Board | 4,09M | N/A | 1967 |
Mr. Jens H. Holstein | CFO & Member of Management Board | 7,17M | N/A | 1963 |
Dr. Sierk Poetting Ph.D. | MD, COO & Member of Management Board | 4,21M | N/A | 1973 |
Mr. Ryan Richardson | Chief Strategy Officer, MD & Member of Management Board | 5,17M | N/A | 1979 |
Mr. Sean Marett | Chief Business Officer, Chief Commercial Officer & Member of Management Board | 4,06M | N/A | 1965 |
Dr. James Timothy Patrick Ryan Ph.D. | Chief Legal Officer & Member of the Management Board | 3,04M | N/A | 1975 |
Mr. Zach Taylor | Senior Vice President of Corporate Development & Strategy | N/A | N/A | N/A |
Dr. Katalin Kariko Ph.D. | Senior VP & External Consultant for RNA Protein Replacement Therapies | N/A | N/A | N/A |
Dr. Oliver Henning Ph.D. | Senior Vice President of Operations | N/A | N/A | N/A |
O QualityScore de governança da ISS da BioNTech SE a partir de 1 de março de 2024 é 5. As principais pontuações para Auditoria são: 6; Conselho: 3; Direitos de Acionistas: 1; Compensação: 7.